{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:07:36Z","timestamp":1794661656911,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["B76C18000520005"],"award-info":[{"award-number":["B76C18000520005"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cannabis is a multifaceted plant with numerous therapeutic properties on one hand, and controversial psychotropic activities on the other hand, which are modulated by CB1 endocannabinoid receptors. \u03949-Tetrahydrocannabinol (\u03949-THC) has been identified as the main component responsible for the psychotropic effects, while its constitutional isomer cannabidiol (CBD) has shown completely different pharmacological properties. Due to its reported beneficial effects, Cannabis has gained global popularity and is openly sold in shops and online. To circumvent legal restrictions, semi-synthetic derivatives of CBD are now frequently added to cannabis products, producing \"high\" effects similar to those induced by \u03949-THC. The first semi-synthetic cannabinoid to appear in the EU was obtained through cyclization and hydrogenation of CBD, and is known as hexahydrocannabinol (HHC). Currently, there is limited knowledge regarding HHC, its pharmacological properties, and its prevalence, as it is not commonly investigated in routine toxicological assays. In this study, synthetic strategies were explored to obtain an excess of the active epimer of HHC. Furthermore, the two epimers were purified and individually tested for their cannabinomimetic activity. Lastly, a simple and rapid chromatographic method employing a UV detector and a high-resolution mass spectrometer was applied to identify and quantify up to ten major phytocannabinoids, as well as the HHC epimers, in commercial cannabis samples.<\/jats:p>","DOI":"10.1038\/s41598-023-38188-5","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T06:02:04Z","timestamp":1688796124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC)"],"prefix":"10.1038","volume":"13","author":[{"given":"Fabiana","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"Vandelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Luongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabatino","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Laura","family":"Capriotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cannazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Citti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"key":"38188_CR1","unstructured":"UNODC. World Drug Report 2021. (United Nations Office on Drugs and Crime, 2021)."},{"key":"38188_CR2","doi-asserted-by":"publisher","first-page":"20335","DOI":"10.1038\/s41598-019-56785-1","volume":"9","author":"C Citti","year":"2019","unstructured":"Citti, C. et al. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than \u03949-tetrahydrocannabinol: \u03949-Tetrahydrocannabiphorol. Sci. Rep. 9, 20335. https:\/\/doi.org\/10.1038\/s41598-019-56785-1 (2019).","journal-title":"Sci. Rep."},{"key":"38188_CR3","doi-asserted-by":"publisher","first-page":"22019","DOI":"10.1038\/s41598-020-79042-2","volume":"10","author":"P Linciano","year":"2020","unstructured":"Linciano, P. et al. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol. Sci. Rep. 10, 22019. https:\/\/doi.org\/10.1038\/s41598-020-79042-2 (2020).","journal-title":"Sci. Rep."},{"key":"38188_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1021\/acs.jnatprod.9b00876","volume":"83","author":"P Linciano","year":"2020","unstructured":"Linciano, P. et al. Isolation of a high-affinity cannabinoid for the human CB1 receptor from a medicinal Cannabis sativa variety: \u03949-tetrahydrocannabutol, the butyl homologue of \u03949-tetrahydrocannabinol. J. Nat. Prod. 83, 88\u201398. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b00876 (2020).","journal-title":"J. Nat. Prod."},{"key":"38188_CR5","doi-asserted-by":"publisher","first-page":"PMC.S32171","DOI":"10.4137\/pmc.s32171","volume":"8","author":"EW Bow","year":"2016","unstructured":"Bow, E. W. & Rimoldi, J. M. The structure-function relationships of classical cannabinoids: CB1\/CB2 modulation. Perspect. Med. Chem. 8, PMC.S32171. https:\/\/doi.org\/10.4137\/pmc.s32171 (2016).","journal-title":"Perspect. Med. Chem."},{"key":"38188_CR6","unstructured":"UNODC. Early warning advisory (EWA) on new psychoactive substances (NPS). (United Nations Office on Drugs and Crime 2017)."},{"key":"38188_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/phar.1424","volume":"34","author":"ME Musselman","year":"2014","unstructured":"Musselman, M. E. & Hampton, J. P. \u201cNot for human consumption\u201d: A review of emerging designer drugs. Pharmacotherapy 34, 745\u2013757. https:\/\/doi.org\/10.1002\/phar.1424 (2014).","journal-title":"Pharmacotherapy"},{"key":"38188_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jep.2006.05.034","volume":"108","author":"H-E Jiang","year":"2006","unstructured":"Jiang, H.-E. et al. A new insight into Cannabis sativa (Cannabaceae) utilization from 2500-year-old Yanghai Tombs, Xinjiang, China. J. Ethnopharmacol. 108, 414\u2013422. https:\/\/doi.org\/10.1016\/j.jep.2006.05.034 (2006).","journal-title":"J. Ethnopharmacol."},{"key":"38188_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/7854_2016_15","volume":"32","author":"F Schifano","year":"2017","unstructured":"Schifano, F., Orsolini, L., Papanti, D. & Corkery, J. NPS: Medical consequences associated with their intake. Curr. Top. Behav. Neurosci. 32, 351\u2013380. https:\/\/doi.org\/10.1007\/7854_2016_15 (2017).","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"38188_CR10","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.2105\/ajph.2021.306499","volume":"111","author":"EC Leas","year":"2021","unstructured":"Leas, E. C. The hemp loophole: A need to clarify the legality of delta-8-THC and other hemp-derived tetrahydrocannabinol compounds. Am. J. Public Health 111, 1927\u20131931. https:\/\/doi.org\/10.2105\/ajph.2021.306499 (2021).","journal-title":"Am. J. Public Health"},{"key":"38188_CR11","unstructured":"EPIDIOLEX, <https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210365lbl.pdf> ("},{"key":"38188_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1089\/can.2020.0021","volume":"6","author":"C Citti","year":"2020","unstructured":"Citti, C. et al. Origin of \u03949-tetrahydrocannabinol impurity in synthetic cannabidiol. Cannabis Cannabinoid Res. 6, 28\u201339. https:\/\/doi.org\/10.1089\/can.2020.0021 (2020).","journal-title":"Cannabis Cannabinoid Res."},{"key":"38188_CR13","unstructured":"(Austria, 1971)."},{"key":"38188_CR14","unstructured":"EMCDDA. (European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 2022)."},{"key":"38188_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1021\/ja01858a058","volume":"62","author":"R Adams","year":"1940","unstructured":"Adams, R., Hunt, M. & Clark, J. H. Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp I.. J. Am. Chem. Soc. 62, 196\u2013200. https:\/\/doi.org\/10.1021\/ja01858a058 (1940).","journal-title":"J. Am. Chem. Soc."},{"key":"38188_CR16","doi-asserted-by":"publisher","DOI":"10.1089\/can.2022.0253","author":"S Casati","year":"2022","unstructured":"Casati, S. et al. Hexahydrocannabinol on the light cannabis market: The latest \u201cnew\u201d entry. Cannabis Cannabinoid Res. https:\/\/doi.org\/10.1089\/can.2022.0253 (2022).","journal-title":"Cannabis Cannabinoid Res."},{"key":"38188_CR17","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1021\/ja01866a040","volume":"62","author":"R Adams","year":"1940","unstructured":"Adams, R., Pease, D., Cain, C. & Clark, J. Structure of cannabidiol. VI. Isomerization of cannabidiol to tetrahydrocannabinol, a physiologically active product. Conversion of cannabidiol to cannabinol1. J. Am. Chem. Soc. 62, 2402\u20132405 (1940).","journal-title":"J. Am. Chem. Soc."},{"key":"38188_CR18","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1021\/ja01866a510","volume":"62","author":"R Adams","year":"1940","unstructured":"Adams, R. et al. Structure of cannabidiol. VIII. Position of the double bonds in cannabidiol. Marihuana activity of tetrahydrocannabinols. J. Am. Chem. Soc. 62, 2566\u20132567. https:\/\/doi.org\/10.1021\/ja01866a510 (1940).","journal-title":"J. Am. Chem. Soc."},{"key":"38188_CR19","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1021\/jm00127a038","volume":"32","author":"PH Reggio","year":"1989","unstructured":"Reggio, P. H., Greer, K. V. & Cox, S. M. The importance of the orientation of the C9 substituent to cannabinoid activity. J. Med. Chem. 32, 1630\u20131635. https:\/\/doi.org\/10.1021\/jm00127a038 (1989).","journal-title":"J. Med. Chem."},{"key":"38188_CR20","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1021\/jm00184a002","volume":"23","author":"R Mechoulam","year":"1980","unstructured":"Mechoulam, R. et al. Stereochemical requirements for cannabinoid activity. J. Med. Chem. 23, 1068\u20131072. https:\/\/doi.org\/10.1021\/jm00184a002 (1980).","journal-title":"J. Med. Chem."},{"key":"38188_CR21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0040-4020(01)99446-3","volume":"22","author":"Y Gaoni","year":"1966","unstructured":"Gaoni, Y. & Mechoulam, R. Hashish\u2014VII: The isomerization of cannabidiol to tetrahydrocannabinols. Tetrahedron 22, 1481\u20131488. https:\/\/doi.org\/10.1016\/S0040-4020(01)99446-3 (1966).","journal-title":"Tetrahedron"},{"key":"38188_CR22","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.1021\/ja00720a033","volume":"92","author":"RA Archer","year":"1970","unstructured":"Archer, R. A., Boyd, D. B., Demarco, P. V., Tyminski, I. J. & Allinger, N. L. Structural studies of cannabinoids. Theoretical and proton magnetic resonance analysis. J. Am. Chem. Soc. 92, 5200\u20135206. https:\/\/doi.org\/10.1021\/ja00720a033 (1970).","journal-title":"J. Am. Chem. Soc."},{"key":"38188_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jpba.2016.05.033","volume":"128","author":"C Citti","year":"2016","unstructured":"Citti, C. et al. Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method. J. Pharm. Biomed. Anal. 128, 201\u2013209. https:\/\/doi.org\/10.1016\/j.jpba.2016.05.033 (2016).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"38188_CR24","unstructured":"Cannabis Flos; New text of the german pharmacopoeia. (2018)."},{"key":"38188_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jpba.2017.05.049","volume":"143","author":"V Brighenti","year":"2017","unstructured":"Brighenti, V., Pellati, F., Steinbach, M., Maran, D. & Benvenuti, S. Development of a new extraction technique and HPLC method for the analysis of non-psychoactive cannabinoids in fibre-type Cannabis sativa L. (hemp). J. Pharm. Biomed. Anal. 143, 228\u2013236. https:\/\/doi.org\/10.1016\/j.jpba.2017.05.049 (2017).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"38188_CR26","doi-asserted-by":"publisher","first-page":"114958","DOI":"10.1016\/j.jpba.2022.114958","volume":"219","author":"F Tolomeo","year":"2022","unstructured":"Tolomeo, F. et al. Cis-\u03949-tetrahydrocannabinolic acid occurrence in Cannabis sativa L.. J. Pharm. Biomed. Anal. 219, 114958. https:\/\/doi.org\/10.1016\/j.jpba.2022.114958 (2022).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"38188_CR27","unstructured":"WHO Expert Committee on Drug Dependence, fortieth report. 25\u201327 (Geneva: World Health Organization, 2018)."},{"key":"38188_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3519","author":"I Ujv\u00e1ry","year":"2023","unstructured":"Ujv\u00e1ry, I. Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review. Drug Test. Anal. https:\/\/doi.org\/10.1002\/dta.3519 (2023).","journal-title":"Drug Test. Anal."},{"key":"38188_CR29","doi-asserted-by":"publisher","first-page":"114215","DOI":"10.1016\/j.jpba.2021.114215","volume":"203","author":"F Tolomeo","year":"2021","unstructured":"Tolomeo, F. et al. HPLC-UV-HRMS analysis of cannabigerovarin and cannabigerobutol, the two impurities of cannabigerol extracted from hemp. J. Pharm. Biomed. Anal. 203, 114215. https:\/\/doi.org\/10.1016\/j.jpba.2021.114215 (2021).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"38188_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/cpns.31","author":"M Metna-Laurent","year":"2017","unstructured":"Metna-Laurent, M., Mond\u00e9sir, M., Grel, A., Vall\u00e9e, M. & Piazza, P.-V. Cannabinoid-induced tetrad in mice. Curr. Protoc. Neurosci. https:\/\/doi.org\/10.1002\/cpns.31 (2017).","journal-title":"Curr. Protoc. Neurosci."},{"key":"38188_CR31","doi-asserted-by":"publisher","first-page":"3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18, 3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410 (2020).","journal-title":"PLoS Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38188-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38188-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38188-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T06:08:16Z","timestamp":1688796496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38188-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38188"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38188-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2650885\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,8]]},"assertion":[{"value":"3 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11061"}}